mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.007 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |